Humana (HUM) option implied volatility elevated into EPS and outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Mizuho Securities Reiterates Buy Rating on Humana (HUM) Following 3Q Beat
November 7, 2019 6:52 AM ESTMizuho Securities analyst Ann Hynes reiterated a Buy rating and $316.00 price target on Humana (NYSE: HUM) following the company's 3Q earnings release. HUM reported 3Q results with a beat on adjusted EPS, revenue and adjusted operating profit. Adjusted EPS of $5.03 beat guidance of $4.58. Total... More
